NOVO HOLDINGS A/S sold 1.0% of their position (40.41K shares) of CYTEIR THERAPEUTICS, INC. on the open market
Open‑market sale worth $71.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 6/28/2023ACC: 0001209191-23-040129
10% Owner
Since Jun 2021
-40.41K
Net shares
Net seller
$71.8K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
40.41K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−8.44K
Price / share
$1.79
Trade value
$15.11K
% of position
0.2%
6/26/2023
3.90M→3.90M
Common Stock
Direct
Shares
−31.98K
Price / share
$1.77
Trade value
$56.69K
% of position
0.8%
6/27/2023
3.90M→3.86M
Total
Net shares
−40.41K
Net value
-$71.79K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/26/2023 | S · Sale | −8.44K | $1.79 | $15.11K | 0.2% | 3.90M | 3.90M |
| Common Stock Direct | 6/27/2023 | S · Sale | −31.98K | $1.77 | $56.69K | 0.8% | 3.90M | 3.86M |
| Total | −40.41K | -$71.79K | ||||||
Derivative Transactions0
No derivative transactions reported